These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12230217)

  • 1. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women.
    Dan M; Poch F; Levin D
    Med Mycol; 2002 Aug; 40(4):383-6. PubMed ID: 12230217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
    Gunther LS; Martins HP; Gimenes F; Abreu AL; Consolaro ME; Svidzinski TI
    Sao Paulo Med J; 2014; 132(2):116-20. PubMed ID: 24714993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
    Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
    Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
    Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L
    New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and management of non-albicans vaginal candidiasis.
    Hettiarachchi N; Ashbee HR; Wilson JD
    Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility profile of vaginal yeast isolates from Brazil.
    Ribeiro MA; Dietze R; Paula CR; Da Matta DA; Colombo AL
    Mycopathologia; 2001; 151(1):5-10. PubMed ID: 11502064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
    Brandão LDS; Boniek D; Resende Stoianoff MA; da Mata FMR; de Azevedo PRM; Fernandes JV; Andrade VS
    Lett Appl Microbiol; 2018 Sep; 67(3):285-291. PubMed ID: 29908032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal yeasts in the era of "over the counter" antifungals.
    Walker PP; Reynolds MT; Ashbee HR; Brown C; Evans EG
    Sex Transm Infect; 2000 Dec; 76(6):437-8. PubMed ID: 11221124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic fungal vaginitis: the value of cultures.
    Nyirjesy P; Seeney SM; Grody MH; Jordan CA; Buckley HR
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):820-3. PubMed ID: 7573250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso.
    Sangaré I; Sirima C; Bamba S; Zida A; Cissé M; Bazié WW; Sanou S; Dao B; Menan H; Guiguemdé RT
    J Mycol Med; 2018 Mar; 28(1):186-192. PubMed ID: 28939305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does vaginal douching affect the type of candidal vulvovaginal infection?
    Shaaban OM; Abbas AM; Moharram AM; Farhan MM; Hassanen IH
    Med Mycol; 2015 Nov; 53(8):817-27. PubMed ID: 26129887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
    Venugopal D; Husain K; Mustafa SA; Sabeen S
    J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.